Reimbursement

The Pharmacy Times® Reimbursement resource center provides clinical news and articles, information about reimbursement for clinical pharmacy services.

What can we help you find?
[[thumbnail_alt_text]]
The Provider Relief Fund, as part of the CARES Act, was an important stopgap for many health care providers across the country, but details on reporting requirements and timing have been elusive.
 
[[thumbnail_alt_text]]
Technology can help revolutionize how a pharmacy manages patients, collects payments, communicates, and can improve overall efficiency.
[[thumbnail_alt_text]]
Protections for covered entities under the 340B program will most likely be affected by decisions in the Senate.
[[thumbnail_alt_text]]
Data standardization has been an ongoing problem in the specialty pharmacy field, affecting both patients and providers when approaching treatments.
[[thumbnail_alt_text]]
During the COVID-19 pandemic, many families and individuals have not been able to pay their out-of-pocket costs or do not have enough money saved to pay their deductibles.
[[thumbnail_alt_text]]
Researchers found that although the number of Medicare beneficiaries increased between 2014 and 2018, total costs decreased.
[[thumbnail_alt_text]]
The terms of participation in the phase 2 round of the Provider Relief Fund created an unintended exclusion for pharmacies that primarily serve Medicaid/Children’s Health Insurance Program patients.
[[thumbnail_alt_text]]
Racial and economic disparities are especially pronounced among patients on Medicare, study shows. 
 
[[thumbnail_alt_text]]
The goals of specialty pharmacy programs are to reduce or delay progression of the disease, improve patient outcomes, enhance patients’ quality of life, keep patients in the workforce longer, and decrease total health care costs.
[[thumbnail_alt_text]]
With election season intensifying, 35% of voters said drug pricing is among the most important issues influencing their vote in November.
[[thumbnail_alt_text]]
More than 40 million unemployment claims have been filed over the course of the COVID-19 pandemic. 
 
[[thumbnail_alt_text]]
NACDS states that although prescription drug discount cards were put in place to reduce out-of-pocket costs, states have been using the data in a manner inconsistent with federal law and policy.